Guido Pizarro

Guido Pizarro

Ask VT AI
View News Summary
  • Trump's media company files for $2.3 billion stock sale, potentially diluting existing shares.
  • FDA delays Novavax COVID vaccine approval, raising concerns about regulatory efficiency after key resignation.
  • Elon Musk's super PAC faces a class-action lawsuit from unpaid canvassers, raising questions about the transparency and ethics of its political funding activities.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Trump's media company files for $2.3 billion stock sale, potentially diluting existing shares.
  • FDA delays Novavax COVID vaccine approval, raising concerns about regulatory efficiency after key resignation.
  • Elon Musk's super PAC faces a class-action lawsuit from unpaid canvassers, raising questions about the transparency and ethics of its political funding activities.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Guido Pizarro